M. Nucifora

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

L. Mazzucchelli, A. Bordoni, M. Pierotti, 2012, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

L. Mazzucchelli, A. Bordoni, M. Pierotti, 2012 .

ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy

Renzo Boldorini, Ottavio Beretta, O. Beretta, 2013, Cancer Chemotherapy and Pharmacology.

Circulating free DNA in a screening program for early colorectal cancer detection.

M. Gariboldi, M. Pierotti, S. Pilotti, 2014, Tumori.

Circulating Free DNA in a Screening Program for Early Colorectal Cancer Detection

M. Gariboldi, M. Pierotti, S. Pilotti, 2014, Tumori.